CN Patent

CN101296909A — 吡嗪衍生物及其作为pi3k抑制剂的应用

Assigned to Merck Serono SA · Expires 2008-10-29 · 18y expired

What this patent protects

本发明涉及特别适合于治疗和/或预防自体免疫失调和/或炎症，心血管疾病，神经退行性疾病，细菌或病毒传染，肾病，血小板凝聚，癌症，移植，移植排斥或者肺损伤的通式(I)的吡嗪衍生物。

USPTO Abstract

本发明涉及特别适合于治疗和/或预防自体免疫失调和/或炎症，心血管疾病，神经退行性疾病，细菌或病毒传染，肾病，血小板凝聚，癌症，移植，移植排斥或者肺损伤的通式(I)的吡嗪衍生物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101296909A
Jurisdiction
CN
Classification
—
Expires
2008-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Merck Serono SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.